Novel Coronavirus (2019-nCoV) or Human Coronavirus (HCoV)
could be a new coronavirus that belongs to Betacoronaviruses type Human
Coronaviruses, just like the Middle-East Respiratory Syndrome (MERS)
coronavirus and Severe Acute Respiratory Syndrome (SARS) coronavirus.
Wuhan, the capital city of Hubei province, China recorded the initial
cases of this virus in December 2019. Until 2 May 2020, 10:00 CET, near
23,8287 deaths were reported out of 3.34 million confirmed cases
recorded across the world. By the tip of January 2020, China confirmed
that the COVID-19 transmitted from human to human. This study aims to
check a completely unique medicament called “Echinacea purpurea”
against the crystal structure of 2019-nCoV Main Protease. This study
presents an ideal model for Echinacea purpurea to be tested in silico
against 2019-nCoV Main Protease.